Task: Answer the multiple choice question.
Question: Which drug has a -0.668% human ether-à-go-go related gene (hERG) inhibition at a concentration of 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a COc1ccccc1-c1nc(C#N)c(N2CCN(Cc3ccccc3)CC2)o1
b CN(C)c1ccc(/C=C2\NC(=S)N(Cc3ccccc3)C2=O)cc1
c COc1cc(/C=C/C(=O)c2ccc(O)cc2)ccc1OCC#N
Answer: b. CN(C)c1ccc(/C=C2\NC(=S)N(Cc3ccccc3)C2=O)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CN(C)c1ccc(/C=C2\NC(=S)N(Cc3ccccc3)C2=O)cc1
CN(C)c1ccc(/C=C2\NC(=S)N(Cc3ccccc3)C2=O)cc1
(5Z)-3-benzyl-5-[[4-(dimethylamino)phenyl]methylidene]-2-sulfanylideneimidazolidin-4-one